SEC Comment Letter for vTv Therapeutics Inc. (VTVT) (CIK 0001641489) (VTVT) — Mar 7, 2018
vTv Therapeutics Inc. (VTVT) (CIK 0001641489)
Date: March 7, 2018 · CIK: 0001641489 · Accession: 0000000000-18-007112
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-223269
Letter
March 7, 2018 Rudy C. Howard Chief Financial Officer vTv Therapeutics Inc. 4170 Mendenhall Oaks Pkwy High Point, NC 27265 Re:vTv Therapeutics Inc. Registration Statement on Form S-3 Filed February 27, 2018 File No. 333-223269 Dear Mr. Howard: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at (202) 551-6761 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Lawrence G. Wee, Esq.
Show Raw Text
March 7, 2018
Rudy C. Howard
Chief Financial Officer
vTv Therapeutics Inc.
4170 Mendenhall Oaks Pkwy
High Point, NC 27265
Re:vTv Therapeutics Inc.
Registration Statement on Form S-3
Filed February 27, 2018
File No. 333-223269
Dear Mr. Howard:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at (202) 551-6761 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Lawrence G. Wee, Esq.